Skip to main content

Table 3 Regression analysis to predict viral load and CD4 count

From: Treatment-associated polymorphisms in protease are significantly associated with higher viral load and lower CD4 count in newly diagnosed drug-naive HIV-1 infected patients

 

Model 1

Model 2

Factors

log VL (95% CI)

p-value

log VL (95% CI)

p-value

TDR PI

-0.073 (-0.287 – 0.140)

0.500

-0.080 (-0.290 – 0.129)

0.451

TDR RTI

-0.009 (-0.157 – 0.138)

0.903

-0.003 (-0.147 – 0.142)

0.971

log10F PI

0.271 (0.122 – 0.420)

0.000

0.251 (0.104 – 0.398)

0.001

log10F RTI

-0.090 (-0.324 – 0.144)

0.449

-0.133 (-0.363 – 0.097)

0.258

log10FPIm

0.314 (0.156 – 0.472)

0.000

0.294 (0.137 – 0.450)

0.000

log10FRTIm

-0.117 (-0.459 – 0.223)

0.498

-0.180 (-0.516 – 0.155)

0.292

Factors

sqrt CD4 (95% CI)

p-value

sqrt CD4 (95% CI)

p-value

TDR PI

-0.357 (-2.313 – 1.600)

0.721

-0.501 (-2.417 – 1.416)

0.609

TDR RTI

0.507 ( -0.844 – 1.859)

0.462

0.362 (-0.963 – 1.688)

0.592

log10F PI

-1.628 (-2.999 – 0.257)

0.020

-1.540 (-2.891 – -0.189)

0.025

log10F RTI

1.465 (-0.683 – 3.613)

0.181

1.583 (-0.527 – 3.692)

0.141

log10FPIm

-1.861 (-3.314 – -0.407)

0.012

-1.779 (-3.213 – -0.346)

0.015

log10FRTIm

1.400 (-1.733 – 4.532)

0.381

1.356 (-1.727 – 4.439)

0.389

  1. Linear regression analyses of the association between genotypic predictors and clinical parameters. Viral load values were log transformed and CD4 counts were square root transformed to approximate the normal distribution. For each of the genotypic predictors, two models including different sets of potential confounders were investigated. Model 1 included genotypic predictors for PR and RT, and estimated duration of infection (recent vs unknown duration). Model 2 additionally included age, gender, risk group and area of origin.